← Open Payments lookup

RACHAEL DRAKE: Open Payments

NPI 1831118421 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,185 in 56 payments from 16 companies in 2025. Trend: 2023 $1,310 · 2024 $1,090 · 2025 $1,185

Food & beverage: $1,185
CompanyPaymentsAmount
ABBVIE INC.18$276
Madrigal Pharmaceuticals6$216
Gilead Sciences, Inc.4$107
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$96
GENZYME CORPORATION3$79
Ardelyx, Inc.3$70
Janssen Biotech, Inc.3$54
Regeneron Healthcare Solutions, Inc.2$53
Phathom Pharmaceuticals, Inc.3$52
Intercept Pharmaceuticals, Inc.3$45

Products named: REZDIFFRA, RINVOQ, DUPIXENT, XIFAXAN, IBSRELA, TREMFYA, MAVYRET, VOQUEZNA.

Industry payments across IN — which companies pay providers there.